FROM LEGACY TO INNOVATION: PIDOTIMOD’S EXPANDING THERAPEUTIC HORIZON: Pidotimod: Revisiting a Classic Immunomodulator. (2025). Mediterranean Journal of Hematology and Infectious Diseases, 17(1), e2025057. https://doi.org/10.4084/MJHID.2025.057